Don't Add the New Travelers' Diarrhea Med Rifamycin (Aemcolo) to Formulary

February 2019

You'll be asked about the role of the new Rx rifamycin (Aemcolo, em-COH-loh) for adults who present with travelers' diarrhea.

Think of rifamycin as similar to rifaximin (Xifaxan). Both meds work locally in the intestines and are minimally absorbed.

But they're not first-line for travelers' diarrhea...and are only effective against noninvasive E. coli strains that don't cause fever or bloody stools.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Anticoagulants Watch for New DOAC Guidance in Your Anticoagulation Policies
Gastroenterology Refocus on Limiting PPIs or H2-Blockers for Stress Ulcer Prophylaxis
Infectious Diseases Reduce Empiric Broad-Spectrum Antibiotics for Pyelonephritis
Antibiotics Add Aortic Aneurysm to the List of Quinolone Concerns
Anticoagulants Avoid Overlapping Direct Oral Anticoagulants With Warfarin in Most Cases
Smoking Cessation Use a Cardiac Admission to Promote Smoking Cessation
Travel Medicine Don't Add the New Travelers' Diarrhea Med Rifamycin (Aemcolo) to Formulary
New Drugs Know How Tolsura Stacks Up to Other Itraconazole Capsules
Vitamins & Minerals Watch for Dosing Confusion With New Vitamin and Supplement Labeling

Don't Add the New Travelers' Diarrhea Med Rifamycin (Aemcolo) to Formulary

Get unlimited access through an Enterprise license

Table of Contents